Capital Group's stake in Zealand Pharma drops below 5%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
June 30, 2026 4:00 PM EDTCompany announcement No. 29 / 2026
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
Copenhagen, Denmark, June 30, 2026Â Zealand Pharma A/S ("the Company" or Zealand Pharma) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports receipt on 30 June 2026 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder:
As of 26 June 2026, The Capital Group Companies, Inc. held voting rights... More
